Jesse Goodman Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Jesse Goodman is of Intellia Therapeutics, Inc.. Currently has a direct ownership of 24,359 shares of NTLA, which is worth approximately $262,833. The most recent transaction as insider was on Jul 01, 2025, when has been sold 1,547 shares (Common Stock) at a price of $9.23 per share, resulting in proceeds of $14,278. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.4K
25.22% 3M change
25.22% 12M change
Total Value Held $262,833

JESSE GOODMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2025
SELL
Open market or private sale
$14,278 $9.23 p/Share
1,547 Reduced 5.97%
24,359 Common Stock
Jun 30 2025
SELL
Open market or private sale
$14,789 $9.56 p/Share
1,547 Reduced 5.64%
25,906 Common Stock
Jun 11 2025
BUY
Grant, award, or other acquisition
-
8,000 Added 22.57%
27,453 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
7,737 Added 28.46%
19,453 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
4,425 Added 27.41%
11,716 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
5,197 Added 41.62%
7,291 Common Stock
Jun 23 2021
BUY
Grant, award, or other acquisition
-
2,094 Added 50.0%
2,094 Common Stock

Also insider at

PHGE
BiomX Inc. Healthcare
Director
JG

Jesse Goodman

Cambridge, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA